Abstract
The in vitro mouse lymphoma cell assay (MLA) is one of the most widely practiced assays in genetic toxicology. MLA detects forward mutations at the thymidine kinase (Tk) locus of the L5178Y (Tk+/− −3.7.2C) cell line derived from a mouse thymic lymphoma. This assay is capable of detecting a wide range of genetic events including point mutations, deletions and multilocus, chromosomal rearrangements, mitotic recombination and nondisjunction. There are two equally accepted versions of the assay, one using soft agar cloning and the second method using liquid media cloning in 96-microwell plates. There are two morphologically distinct types of mutant colonies recovered in the MLA; small and large colony mutants. The induction of small colony mutants is associated with chemicals inducing gross chromosomal aberrations, whereas the induction of large mutant colonies is generally associated with chemicals inducing point mutations. The source and karyotype of the cell line as well as the culture conditions are important variables that could influence the assay performance. The assay when performed according to the standards recommended by the International Workshops on Genotoxicity Testing (IWGT) and the Organization of Economic Cooperation and Development Test Guideline 490 is capable of providing valuable genotoxicity hazard information as part of the overall safety assessment process of various classes of test substances.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clive D, Flamm GW, Patterson JB (1973) Specific-locus mutational assay systems for mouse lymphoma cells. In: Hollaender A (ed) Chemical mutagens: principles and methods for their detection, vol 3. Plenum Press, New York-London, pp 79–103
Clive D, Spector JF (1975) Laboratory procedure for assessing specific locus mutations at the Tk locus in cultured L5178Y mouse lymphoma cells. Mutat Res 31:17–29
Clive D, Caspery W, Kirby PE et al (1987) Guide for performing the mouse lymphoma assay for mammalian cell mutagenicity. Mutat Res 189:143–156
Applegate ML, Moore MM, Broder CB et al (1990) Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc Natl Acad Sci 87(1):51–55
Moore MM, Clive D, Hozier JC et al (1985) Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/− mouse lymphoma cells. Mutat Res 151(1):161–174
Wang J, Sawyer JR, Chen L et al (2009) The mouse lymphoma assay detects recombination, deletion, and aneuploidy. Toxicol Sci 109(1):96–105
Dearfield KL, Auletta AE, Cimino MC et al (1991) Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity. Mutat Res 258:259–283
OECD (2016) In vitro mammalian cell gene mutation test using the thymidine kinase gene, OECD guideline for testing of chemicals, no. 490. OECD Guidelines for the Testing of Chemicals, Section 4, Paris, France
FDA (2001) Mouse lymphoma thymidine kinase gene mutation assay. http://wwwcfsanfdagov/~redbook/redivc1chtmL, 2001
The International Conference on Harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use ICH S2 R1 (2011) Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. November 9, 2011
Hozier J, Sawyer J, Moore M et al (1981) Cytogenetic analysis of the L5178Y/TK+/− leads to TK−/− mouse lymphoma mutagenesis assay system. Mutat Res 84(1):169–181
Sawyer J, Moore MM, Clive D et al (1985) Cytogenetic characterization of the L5178Y TK+/−-3.7.2C mouse lymphoma cell line. Mutat Res 147(5):243–253
Lorge E, Moore MM, Clements J et al (2016) Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing. Mutat Res 809:1–15
Charles GD, Spencer PJ, Schisler MR et al (2005) Mode of mutagenic action for the biocide Bioban CS-1246 in mouse lymphoma cells and implications for its in vivo mutagenic potential. Toxicol Sci 84:73–80
Moore MM, Honma M, Clements J et al (2003) Mouse lymphoma thymidine kinase gene mutation assay: international workshop on genotoxicity tests workgroup report-plymouth, UK 2002. Mutat Res 540:127–140
Moore MM, Honma M, Clements J et al (2006) Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the international workshop on genotoxicity testing-aberdeen, Scotland, 2003-assay acceptance criteria, positive controls, and data evaluation. Environ Mol Mutagen 47(1):1–5
Sawyer JR, Moore MM, Hozier JC (1989) High-resolution cytogenetic characterization of the L5178Y TK+/− mouse lymphoma cell line. Mutat Res 214(2):195–199
Sawyer JR, Binz RL, Wang J et al (2006) Multicolor spectral karyotyping of the L5178Y Tk+/− 3.7.2C mouse lymphoma cell line. Environ Mol Mutagen 47(2):127–131
Storer RD, Kraynak AR, McKelvey TW et al (1997) The mouse lymphoma L5178Y Tk+/− cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutat Res 373(2):157–165
Clark LS, Hart DW, Vojta PJ (1998) Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y Tk+/− 3.7.2C mouse lymphoma cells. Mutagenesis 13:427–434
O’Neill JP, Machanoff R, San Sebastian JR et al (1982) Cytotoxicity and mutagenicity of dimethylnitrosamine in mammalian cells (CHO/HGPRT system): enhancement by calcium phosphate. Environ Mutagen 4:7–18
Thilagar AK, Kumaroo PV, Kott S (1984) Effects of low pH caused by glacial acetic acid and hydrochloric acid on chromosomal aberrations in CHO Cells. Toxicologist 4:51
Galloway SM, Bean CL, Armstrong MA et al (1985) False positive in vitro chromosome aberration tests with non mutagens at high concentrations and osmolalities. Environ Mutagen 7(3):48–49
Cifone MA (1985) Relationship between increases in the mutant frequency in L5178Y Tk+/− mouse lymphoma cells at low pH and metabolic activation. Environ Mutagen 7(3):27
Clive D, Johnson KO, Spector JFS et al (1979) Validation and characterization of the L5178Y/TK+/− mouse lymphoma mutagen assay system. Mutat Res 59:61–108
Robinson WD, Green MHL, Cole J et al (1989) Statistical evaluation of bacterial/mammalian fluctuation tests. In: Kirkland DJ (ed) Statistical evaluation of mutagenicity test data. Cambridge University Press, Cambridge, pp 102–140
Mitchell AD, Auletta AE, Clive DC et al (1997) The L5178Y/tk+/− mouse lymphoma specific gene and chromosomal mutation assay. A phase III report of the US Environmental Protection Agency Gene-Tox Program. Mutat Res 394:177–303
Kirkland D, Aardema M, Henderson L et al (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res 584:1–256
Kirkland D, Aardema M, Müller L et al (2006) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutat Res 608:29–42
Schisler MR, Gollapudi BB, Moore MM (2018) Evaluation of U.S. national toxicology program (NTP) mouse lymphoma assay data using international workshop on genotoxicity tests (IWGT) and the Organization for economic co-operation and development (OECD) Criteria, Env. Molec. Mutagenesis 59:829–841
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Schisler, M.R., Moore, M.M., Gollapudi, B.B. (2019). In Vitro Mouse Lymphoma Cell (L5178Y Tk+/− −3.7.2.C) Forward Mutation Assay. In: Dhawan, A., Bajpayee, M. (eds) Genotoxicity Assessment. Methods in Molecular Biology, vol 2031. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9646-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9646-9_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9645-2
Online ISBN: 978-1-4939-9646-9
eBook Packages: Springer Protocols